P1172: Real world experience using advanced therapies to treat Inflammatory Bowel Disease in patients with a Liver TransplantECCO'25Year: 2025
Authors: Campbell, S.(1)*;Rak, A.(2);Radia, C.(2);Frolkis, A.(1);Patel, M.(2);Dubois, P.(2);Hakeen, A.(3);Pavlidis, P.(2);Cortes-Cerisuelo, M.(3);Joshi, D.(1);Kent, A.(2);
(1)King’s College Hospital- London- UK, Hepatology, London, United Kingdom;(2)King’s College Hospital- London- UK, Gastroenterology, London, United Kingdom;(3)King’s College Hospital- London- UK, Liver Transplant Surgery, London, United Kingdom;
1. Rodriguez-Duque JC, Calleja JL, Iruzubieta P, Hernández-Conde M, Rivas-Rivas C, Vera MI, Garcia MJ, Pascual M, Castro B, García-Blanco A, García-Nieto E, Olmo SC, Cagigal ML, Lopez-Montejo L, Fernández-Lamas T, Rasines L, Fortea JI, Vaque JP, Frias Y, Rivero M, Arias-Loste MT, Crespo J. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors. Clin Gastroenterol Hepatol. 2023 Feb;21(2):406-414.e7.
2. Westerouen van Meeteren MJ et al. Safety of anti-TNF treatment in liver transplant recipients: A systematic review and meta-analysis. Journal of Crohn's and Colitis. 2017; Vol. 11, pp. 1146-1151.
P1173: Results of salvage ileal-pouch-anal anastomosis surgery in Ulcerative Colitis patients with restorative proctocolectomy.ECCO'25Year: 2025
Authors: Altieri, C.(1)*;Emma, E.P.(1);Luceri, C.(2);Vacca, L.(1);Cricchio, M.(1);Perna, F.(1);Ficari, F.(1);Scaringi, S.(1);
(1)Careggi University Hospital, Digestive and IBD Surgical Unit, Florence, Italy;(2)University of Florence, NEUROFARBA- Section of Pharmacology and Toxicology, Florence, Italy;
P1174: Engineering therapeutic Tregs to overexpress GPR15 improves functional fitness for in vivo gut homing.ECCO'25Year: 2025
Authors: Müller, T.M.(1)*;Liu, L.J.(1);Wiesinger, M.(2);Atreya, I.(1);Siegmund, B.(3);Atreya, R.(1);Berking, C.(2);Neurath, M.F.(1);Bosch-Voskens, C.(2);Zundler, S.(1);
(1)Uniklinikum Erlangen, Medizinische Klinik 1, Erlangen, Germany;(2)Uniklinikum Erlangen, Hautklinik, Erlangen, Germany;(3)Charité Universitätsmedizin Berlin, Medizinischen Klinik für Gastroenterologie- Infektiologie und Rheumatologie, Berlin, Germany;
P1175: Handheld ultrasound devices are an accurate alternative to cart-based ultrasound for IBD disease activity assessmentECCO'25Year: 2025
Authors: Fernandes, R.(1)*;Swe, E.(1);Khaing, M.M.(1);Gilmore, R.(1);Khoo, E.(1);An, Y.K.(1);Begun, J.(1);
(1)Mater Hospital Brisbane, Gastroenterology, South Brisbane, Australia;
P1176: Low serum albumin levels are associated with higher colectomy rates in patients with moderate-to-severe ulcerative colitis on tofacitinib.ECCO'25Year: 2025
Authors: ParraPhD, R.(1)*;Fróes, R.D.S.B.(2);Magro, D.O.(3);Ferreira, S.D.C.(4);Mello, M.K.D.(5);Azevedo, M.F.C.D.(6);Damiao, A.O.M.C.(6);Carlos, A.D.S.(6);Barros, L.L.(6);Miranda, M.L.Q.D.(7);Zabot, G.P.(8);Vieira, A.(7);Sales, M.P.M.(9);Chebli, L.A.(9);Cassol, O.S.(10);Lubini, M.(11);Alves Jr, A.J.T.(12);Machado, M.B.(13);Flores, C.(14);Teixeira, F.V.(15);Coy, C.S.R.(16);Zaltman, C.(17);Sassaki, L.Y.(18);Feres, O.(19);Chebli, J.M.F.(9);
(1)University of Sao Paulo Faculty of Medicine of Ribeirao Preto, Department of Surgery and Anatomy, Ribeirao Preto- SP, Brazil;(2)Gastromed, Gastroenterology and Endoscopy, Rio de Janeiro, Brazil;(3)Unicamp, Department of Surgery, Campinas, Brazil;(4)Ribeirao Preto Medical School- University of São Paulo, Gastroenterology, Ribeirao Preto, Brazil;(5)University of Vale do Itajaí, Gastroenterology, Itajaí, Brazil;(6)University of São Paulo School of Medicine, Gastroenterology, Sao Paulo, Brazil;(7)Santa Casa Sao Paulo Medical School, Department of Internal Medicine, Sao Paulo, Brazil;(8)Moinhos de Vento Hospital- Feevale University, Department of Colon and Rectum Surgery, Porto Alegre, Brazil;(9)Federal University of Juiz de Fora, Division of Gastroenterology- Department of Medicine- Inflammatory Bowel Disease Center, Juiz de Fora, Brazil;(10)Hospital de Clínicas de Passo Fundo- Atitus Medical School, Department of Colorectal Surgery, Passo Fundo, Brazil;(11)Passo Fundo University, Gastroenterology, Passo Fundo, Brazil;(12)PUC-Campinas Medical School, Department of Surgery, Campinas, Brazil;(13)University Cattholic PUC-RS, Gastroenterology, Porto Alegra, Brazil;(14)Reference Center in Crohn and Colitis- Digestive System Institute, Gastroenterology, Porto Alegra, Brazil;(15)Gastrosaude, Gastroenterology, Marilia - SP, Brazil;(16)Unicamp, Surgery, Campinas, Brazil;(17)Federal University of Rio de Janeiro, Gastroenterology, Rio de Janeiro, Brazil;(18)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(19)Ribeirao Preto Medical School- University of São Paulo, Surgery and Anatomy, Ribeirão Preto, Brazil;
P1177: Factors Driving Persistence to First-Line Advanced Therapies in Inflammatory Bowel Disease – A Real-World StudyECCO'25Year: 2025
Authors: Santacroce, G.(1,2)*;Lenti, M.V.(1,2);Lepore, F.(1,2);Mordà, F.(1,2);Lo Bello, A.(1,2);Aronico, N.(2);Mengoli, C.(2);Delliponti, M.(3);Di Sabatino, A.(1,2);
(1)University of Pavia, Department of Internal Medicine and Medical Therapeutics, Pavia, Italy;(2)San Matteo Hospital Foundation, First Department of Internal Medicine, Pavia, Italy;(3)San Matteo Hospital Foundation, SSD Biostatistica and Clinical Trial, Pavia, Italy;
P1178: A multi-centred retrospective cohort study comparing JAK inhibitor therapies in moderate to severe ulcerative colitisECCO'25Year: 2025
Authors: Kumar, A.(1)*;Bower, J.(2);Rimmer, P.(3);Noble, B.(1);Makki, M.(4);Chikhlia, A.(4);Cheesbrough, J.(3);Disney, B.(4);Muir, J.(5);Karova, M.(6);Butterworth, J.(5);Bower, J.(4);Sagar, N.(2);Al-Talib, I.(2);Nahal, J.(2);Hatta, A.(4);Ali, N.(7);Sagar, V.(7);Varyani, F.(7);Smith, S.(8);Bourne, S.(9);Hsu, Y.K.(10);Eltahir, A.(10);de silva, S.(10);Harvey, P.(1);
(1)The Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(2)Walsall Manor NHS Trust, Gastroenterology, Walsall, United Kingdom;(3)University Hospitals Birmingham, Gastroenterology, Birmingham, United Kingdom;(4)University Hospitals Coventry & Warwickshire, Gastroenterology, Coventry, United Kingdom;(5)Shrewsbury & Telford NHS Trust, Gastroenterology, Shrewsbury, United Kingdom;(6)Shrewsbury & Telford NHS Trust, Gastroenterology, Shrewbury, United Kingdom;(7)Sandwell General Hospital, Gastroenterology, Birmingham, United Kingdom;(8)Worcester Royal Hospital, Gastroenterology, Worcester, United Kingdom;(9)Royal Stoke University Hospital, Gastroenterology, Stoke, United Kingdom;(10)Dudley Group NHS Trust, Gastroenterology, Dudley, United Kingdom;
P1179: Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy (RETUCAS): a Multicentre Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)ECCO'25Year: 2025
Authors: Macaluso, F.S.(1)*;Grova, M.(2);Bossa, F.(3);Carparelli, S.(3);Pugliese, D.(4);Cuccia, G.(4);Cappello, M.(5);Muscarella, S.(5);Saibeni, S.(6);Bezzio, C.(7);Armuzzi, A.(7);Gravina, G.A.(8);Pellegrino, R.(8);Caprioli, F.A.(9);Sorge, A.(9);Soriano, A.(10);Ribaldone, D.G.(11);Festa, S.(12);Variola, A.(13);Ferracane, C.(14);Onali, S.(15);Fantini, M.C.(15);Orlando, A.(1);
(1)"Villa Sofia-Cervello" Hospital, IBD Unit, Palermo, Italy;(2)"Villa Sofia-Cervello" Hospital, Digestive Endoscopy Unit, Palermo, Italy;(3)Fondazione IRCCS Casa Sollievo Della Sofferenza, Gastroenterology and Endoscopy Unit, San Giovanni Rotondo, Italy;(4)Università Cattolica del Sacro Cuore, Dipartimento di Medicina e Chirurgia Traslazionale, Rome, Italy;(5)University of Palermo, Gastroenterology & Hepatology Section- PROMISE, Palermo, Italy;(6)Rho Hospital- ASST Rhodense, Gastroenterology Unit-, Rho, Italy;(7)IRCCS Humanitas Research Hospital, IBD Center, Rozzano- Milan, Italy;(8)University of Campania Luigi Vanvitelli, Hepatogastroenterology Division- Department of Precision Medicine, Naples, Italy;(9)University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy;(10)Arcispedale S.Maria Nuova, IBD Unit, Reggio Emilia, Italy;(11)University of Turin, Department of Medical Sciences- Division of Gastroenterology, Turin, Italy;(12)"San Filippo Neri" Hospital, IBD Unit, Rome, Italy;(13)IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy;(14)“Vittorio Emanuele” Hospital, Gastroenterology Unit, Catania, Italy;(15)University of Cagliari, Department of Medical Science and Public Health, Cagliari, Italy; Italian Group for the study of Inflammatory Bowel Diseases (IG-IBD)
P1181: Liver fibrosis predicts response to advanced therapy in inflammatory bowel disease: a new personalized treatment approach?ECCO'25Year: 2025
Authors: Bencardino, S.(1)*;D’Amico, F.(1);Barà, R.(1);Allocca, M.(1);Zilli, A.(1);Furfaro, F.(1);Parigi, T.L.(1);Ungaro, F.(2);Fiorino, G.(3);Peyrin-Biroulet, L.(4);Massimino, L.(5);Danese, S.(1);Moschetta, A.(6);
(1)IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Department of Gastroenterology and Endoscopy, Milan, Italy;(2)IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Experimental Gastroenterology Unit- Division of Immunology- Transplantation and Infectious Disease, Milan, Italy;(3)San Camillo-Forlanini Hospital, IBD Unit- Department of Gastroenterology & Digestive Endoscopy, Rome, Italy;(4)INFINY Institute- INSERM NGERE- CHRU Nancy, Department of Gastroenterology, Nancy, France;(5)IRCCS Ospedale San Raffaele, Experimental Gastroenterology Unit- Division of Immunology- Transplantation and Infectious Disease, Milan, Italy;(6)University Hospital of Bari, Department of Internal Medicine- and Rare Diseases Centre "C. Frugoni", Bari, Italy;
1. Tseng PL, Wang JH, Hung CH, et al. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. Kaohsiung J Med Sci. 2013;29(7):385-395. doi:10.1016/j.kjms.2012.11.007
2. Huttman M, Parigi TL, Zoncapè M, et al. Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C. Cochrane Database Syst Rev. 2024;8(8):CD011929. doi:10.1002/14651858.CD011929.pub2
3. Wang HW, Peng CY, Lai HC, et al. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep. 2017;7(1):3259. doi:10.1038/s41598-017-03589-w
P1182: Risk of surgery in patients with newly diagnosed Crohn's disease is declining along the 21st centuryECCO'25Year: 2025
Authors: Kontola, K.(1)*;Oksanen, P.(2,3);Huhtala, H.(4);Helavirta, I.(2,3);Ilus, T.(2);
(1)The Wellbeing Services County of South Ostrobothnia, Internal Medicine, Seinäjoki, Finland;(2)Tampere University Hospital, Department of Gastroenterology and Alimentary Tract Surgery, Tampere, Finland;(3)Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland;(4)Tampere University, Faculty of Social Sciences, Tampere, Finland;
P1183: Multivariable analysis of baseline variables associated with efficacy outcomes in the ELEVATE UC clinical programmeECCO'25Year: 2025
Authors: Feagan, B.G.(1,2)*;Kayal, M.(3);Schreiber, S.(4);Abreu, M.T.(5);Banerjee, R.(6);Fellmann, M.(7);Abbatemarco, A.M.(8);Woolcott, J.C.(9);Wu, J.(10);Goetsch, M.(7);Keating, M.(8);Rubin, D.T.(11);
(1)Western University, Division of Gastroenterology- Department of Medicine, London- ON, Canada;(2)., Alimentiv Inc, London- ON, Canada;(3)Icahn School of Medicine at Mount Sinai, Susan and Leonard Feinstein IBD Center, New York- NY, United States;(4)University Hospital Schleswig-Holstein- Kiel University, Department of Internal Medicine I, Kiel, Germany;(5)Cedars-Sinai Medical Center, F. Widjaja Inflammatory Bowel Disease Institute, Los Angeles- CA, United States;(6)Asian Institute of Gastroenterology, IBD Center, Hyderabad, India;(7)., Pfizer AG, Zürich, Switzerland;(8)., Pfizer Inc, New York- NY, United States;(9)., Pfizer Inc, Collegeville- PA, United States;(10)., Pfizer Inc, Cambridge- MA, United States;(11)University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago- IL, United States;
References1. Sandborn WJ et al. Lancet 2023; 401: 1159–1171.
Pfizer’s generative artificial intelligence tool MAIA was used to assist production of the abstract first draft. Authors reviewed/edited and take responsibility for the content.
P1184: Comprehensive IBD Care: Introduction of an IBD-specialized psychologist in a multidisciplinary IBD teamECCO'25Year: 2025
Authors: Keersmaekers, B.(1)*;Vanderbist, K.(1);Vermeire, S.(1);Verstockt, B.(1);Sabino, J.(1);Ferrante, M.(1);
(1)UZ Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
Fiorino G, Lytras T, Younge L, Fidalgo C, Coenen S, Chaparro M, Allocca M, Arnott I, Bossuyt P, Burisch J, Campmans-Kuijpers M, de Ridder L, Dignass A, Drohan C, Feakins R, Gilardi D, Grosek J, Groß E, Hart A, Jäghult S, Katsanos K, Lönnfors S, Panis Y, Perovic M, Pierik M, Rimola J, Tulchinsky H, Gisbert JP. Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper. J Crohns Colitis. 2020 Sep 7;14(8):1037-1048.
P1185: Preoperative bowel preparation in Crohn’s disease patients: final results of the prospective observational studyECCO'25Year: 2025
Authors: Iesalnieks, I.(1)*;Bercher, M.(2);Schmitz, A.(3);
(1)Evangelisches Krankenhaus Kalk, Department of surgery, Cologne, Germany;(2)Evangelisches Krankenhaus Kalk, Sugery, Cologne, Germany;(3)Evangelisches Krankenhaus Kalk, Surgery, Cologne, Germany;
P1186: Transperineal ultrasound is accurate in detecting perianal complications in Crohn’s disease: a systematic review and meta-analysis.ECCO'25Year: 2025
Authors: Lim, C.T.(1,2)*;Pruijt, M.(2);Lim, G.H.(3);van Etten-Jamaludin, F.(4);Teichert, C.(2);de Voogd, F.(2);Christensen, B.(5,6);D'Haens, G.(2);Maconi, G.(7);Gecse, K.(2);
(1)Singapore General Hospital, Gastroenterology and Hepatology, Singapore, Singapore;(2)Amsterdam University Medical Centre, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(3)Singapore General Hospital, Health Services Research Unit, Singapore, Singapore;(4)Amsterdam University Medical Centre, Medical Library, Amsterdam, The Netherlands;(5)The Royal Melbourne Hospital, Department of Gastroenterology, Melbourne, Australia;(6)University of Melbourne, Department of Medicine, Melbourne, Australia;(7)“L. Sacco” Hospital- University of Milano, Gastroenterology Unit- Department of Biomedical and Clinical Sciences, Milan, Italy;
P1187: Healthcare professionals’ experiences of assessing and managing IBD-related fatigue in clinical practice – a mixed methods studyECCO'25Year: 2025
Authors: Watson, N.(1)*;Chalmers, D.(2);Czuber-Dochan , W.(3);
(1)King's college London, Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;(2)King’s College London, IoPPN Health Psychology, London, United Kingdom;(3)King’s College London, Faculty of Nursing- Midwifery & Palliative Care, London, United Kingdom;
[1] Czuber-Dochan, W., Norton, C., Bredin, F., Darvell, M., Nathan, I., & Terry, H. (2014). Healthcare professionals' perceptions of fatigue experienced by people with IBD. Journal of Crohn's and Colitis, 8(8), 835-844.
[2] Czuber-Dochan, W., Norton, C., Bassett, P., Berliner, S., Bredin, F., Darvell, M., ... & Terry, H. (2014). Development and psychometric testing of inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale. Journal of Crohn's and Colitis, 8(11), 1398-1406.
P1188: Real-world quality of life experience of subcutaneous infliximab use in children with Inflammatory Bowel Disease (IBD) at a tertiary paediatric centreECCO'25Year: 2025
Authors: Dutt, S.(1,2)*;Chidgey, T.(1);Chuah, C.W.(1);Eldredge, J.(1);Magoffin, A.(1);Puppi, J.(1);Siew, S.(1,2);Singh, N.(3);Stormon, M.(1);Tano, M.(1);Thacker, K.(1);O'Loughlin, E.V.(1);
(1)The Children's Hospital at Westmead, Department of Gastroenterology, Westmead, Australia;(2)University of Sydney, Children's Hospital Westmead Clinical School- Sydney School of Medicine, Sydney, Australia;(3)The Children's Hospital at Westmead, Pharmacy, Westmead, Australia;
1) Schreiber S, Ben-Horin S, Leszczyszyn J et al. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease. Gastroenterology 2021; 160: 2340-53.
2) Buisson A, Nachury M, Bazoge M et al. Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study. Aliment Pharmacol Ther 2024; 59: 526-34.
3) Gianolio L, Armstrong K, Swann E et al. Effectiveness of Switching to Subcutaneous Infliximab in Pediatric Inflammatory Bowel Disease Patients on Intravenous Maintenance Therapy. J Pediatr Gastroenterol Nutr 2023; 77: 235-9.
4) Gianolio L, Armstrong K, Swann E et al. OC5 Effectiveness and safety of switching to subcutaneous infliximab in paediatric inflammatory bowel disease patients on established intravenous biosimilar infliximab maintenance therapy: real world data from a regional cohort. Frontline Gastroenterology 2024; 15: A4-A.
P1189: Rethinking disease clearance in ulcerative colitis: histological activity predicts long-term outcomes in an Argentine reference center cohortECCO'25Year: 2025
Authors: Marturano, M.V.(1);Gómez, E.J.(1);Navar, S.(1);Rodriguez Mesias, J.L.(1);Amante, M.F.(2);Gonzalez, R.A.(1)*;
(1)Inflammatory Bowel Disease Unit- Digestive Diseases Institute, Hospital Alemán, Ciudad de Buenos Aires, Argentina;(2)Pathology Department, Hospital Alemán, Ciudad de Buenos Aires, Argentina;
P1190: Generation of blood-derived reference samples with endogenous cytokinesECCO'25Year: 2025
Authors: Bain-Wendlinger , C.(1)*;Lavocat , F.(2);Poyau , A.(2);Silva , J.(3);Cousin , E.(2);Serraz , C.(3);
(1)KCAS Bio, Scientific direction, LYON, France;(2)KCAS Bio, Method development, lyon, France;(3)KCAS Bio, Bioanalysis, Lyon, France;
P1191: Early Clinical, Biological, and Sonographic Response in Ileal Crohn’s Disease Patients Treated with Upadacitinib: A Single-Centre Real-World ExperienceECCO'25Year: 2025
Authors: Maria, A.(1)*;Laura, C.(1);David, R.D.L.C.(1);cristina, O.(1);Carmen, G.(2);Berta, D.L.H.(3);Francisco, L.(1);Ángeles, M.(1);carmen, Y.(1);Begoña, C.(1);Yago, G.L.(1);
(1)Digestive Medicine Department. Gastroenterology Section. IBD Unit. Hospital Universitario 12 de Octubre. Madrid. Spain., Digestive Medicine Department. Gastroenterology Section. IBD Unit. Hospital Universitario 12 de Octubre. Madrid. Spain., Madrid, Spain;(2)Pharmacology Department. Hospital Universitario 12 de Octubre. Madrid. Spain., Pharmacology Department. Hospital Universitario 12 de Octubre. Madrid. Spain., madrid, Spain;(3)Digestive Medicine Department. Hepatology Section. IBD Unit. Hospital Universitario 12 de Octubre. Madrid. Spain., Digestive Medicine Department. Hepatology Section. IBD Unit. Hospital Universitario 12 de Octubre. Madrid. Spain., madrid, Spain;
